Sort   by:  
 Page size 
UnknownRandomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.
Not available
S-EPMC5569691 | biostudies-literature
UnknownPrinciples and reality of proton therapy treatment allocation.
Not available
S-EPMC4278661 | biostudies-literature
UnknownDouble-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Not available
S-EPMC4104290 | biostudies-literature
UnknownIdentifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study).
Not available
S-EPMC9298773 | biostudies-literature
UnknownSustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.
Not available
S-EPMC10034754 | biostudies-literature
UnknownAssessing delayed penicillin hypersensitivity using the PENFAST+ score.
Not available
S-EPMC10680989 | biostudies-literature
UnknownExtracellular vesicles in systemic juvenile idiopathic arthritis.
Not available
S-EPMC10602196 | biostudies-literature
UnknownUrticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report.
Not available
S-EPMC10156422 | biostudies-literature
UnknownA phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors.
Not available
S-EPMC7574157 | biostudies-literature
UnknownPhase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.
Not available
S-EPMC5988656 | biostudies-literature
Sort   by:  
 Page size